EUVIMEDEUVIMED entdecken
Crossref

The ımpact of the novel tumor marker ındex (TMI) on survival and prognosis in metastatic gastric cancer

Ozge Demirkiran, Bilgin Demir, Onur Y Balcik, Tugay Avci, Atike P Erdogan, Ferhat Ekinci, Seray Saray, Omer Acar, Nazan Demir, Ali Aytac, Ismail Beypinar, Esin Oktay

American Journal of Cancer Research · 2026 · 16 (10) · 4481-4493

DOI: 10.62347/jgid2940 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Ozge Demirkiran und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Demirkiran, O., Demir, B., Balcik, O. Y., Avci, T., Erdogan, A. P., Ekinci, F., Saray, S., Acar, O., Demir, N., Aytac, A., Beypinar, I., & Oktay, E. (2026). The ımpact of the novel tumor marker ındex (TMI) on survival and prognosis in metastatic gastric cancer. American Journal of Cancer Research, 16(10), 4481-4493. https://doi.org/10.62347/jgid2940

Vancouver

Demirkiran O, Demir B, Balcik OY, Avci T, Erdogan AP, Ekinci F, et al. The ımpact of the novel tumor marker ındex (TMI) on survival and prognosis in metastatic gastric cancer. American Journal of Cancer Research. 2026;16(10):4481-4493. doi:10.62347/jgid2940

BibTeX
@article{Demirkiran2026,
  author = {Demirkiran, Ozge and Demir, Bilgin and Balcik, Onur Y and Avci, Tugay and Erdogan, Atike P and Ekinci, Ferhat and Saray, Seray and Acar, Omer and Demir, Nazan and Aytac, Ali and Beypinar, Ismail and Oktay, Esin},
  title = {The ımpact of the novel tumor marker ındex (TMI) on survival and prognosis in metastatic gastric cancer},
  journal = {American Journal of Cancer Research},
  year = {2026},
  volume = {16},
  number = {10},
  pages = {4481--4493},
  doi = {10.62347/jgid2940}
}
Kostenlos starten →